Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1975-03-19
1977-08-02
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
536 4, 536 17, 536 18, 536115, 536122, A61K 3171, C07H 1100
Patent
active
040396630
ABSTRACT:
The known antibiotic daunomycin, and the novel compounds daunomycin-.beta.-anomer and 4'-epidaunomycin (both .alpha.- and .beta.-anomers) are prepared by condensing daunomycinone with reactive novel intermediates which are 1-chloro-2,3,6-trideoxy-3-trifluoroacetamido-4-trifluoroacetoxy-.alpha.-L- lyxo (or arabino) hexopyranoses.
REFERENCES:
patent: 2949449 (1960-08-01), Hoffer
patent: 3356674 (1967-12-01), Ikeda et al.
patent: 3427300 (1969-02-01), Sarett et al.
patent: 3501456 (1970-03-01), Shen et al.
patent: 3524844 (1970-08-01), Keller-Juslen et al.
patent: 3686163 (1972-08-01), Arcamone et al.
patent: 3803124 (1974-04-01), Arcamone et al.
Arcamone Federico
di Marco Aurelio
Penco Sergio
Brown Johnnie R.
Societa Farmaceutici Italia S.p.A.
LandOfFree
Daunomycins, process for their uses and intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Daunomycins, process for their uses and intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Daunomycins, process for their uses and intermediates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2299344